comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 14:58:52 - browse：6

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Gilead might be held responsible for not developing a drug

Wikipedia

WSS

What a koala virus tells us about the human genome

For Medicare Advantage, Democrats want stronger protections around AI

Abbott's new stent may help patients with peripheral artery disease

BioAge raises $170M for combination therapy with Zepbound

Fertility clinic egg and embryo storage is a disaster

Private equity deals in Medicare Advantage declines

focus

comprehensive

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lilly’s weekly insulin works as well as daily products, new studies show

Continuity nursing helped my family in our darkest PICU moments

Vaccine advisory panel ACIP left half staffed by HHS

George Santos makes 1st court appearance after pleading not guilty to 13 counts

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

State Dept. review finds Biden bears some blame for Afghanistan failures

A disappointing year of Humira biosimilars

Heart attack and stroke risk calculators need revising

Cherokee Nation medical school graduates its first class

focus

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Fertility clinic egg and embryo storage is a disaster

Biogen Alzheimer’s drug launch off to slow start

Abbott's new stent may help patients with peripheral artery disease

Hottest summer in 2,000 years puts focus on extreme heat, health

As H5N1 spreads in cows, experts warn against drinking raw milk

focus

entertainment

Wikipedia

Wikipedia